Remove Communication Remove Documentation Remove Download
article thumbnail

U.S. Pharmaceutical company improved quality of overall documentation saving time and filing delays

Impact Pharmaceutical Services

Challenge Syner-G was contracted by a US Pharmaceutical Company to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. Results Syner-G reviewed each documentation and provided suggestions/comments/guidance to the CDMO to bridge the gaps observed.

article thumbnail

Is my Software a Medical Device? Use the Digital Health Policy Navigator

The FDA Law Blog

It identifies key questions to consider that originate from a variety of FDA guidance documents and aggregates the information into a one-stop shop. The following Guidance documents are critical to understanding the FDA’s policy for software products: Changes to Existing Medical Software Policies. The flowchart can be downloaded here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases. This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development.

FDA 105
article thumbnail

Leading direct-to-consumer marketing companies for pharmaceuticals

Pharmaceutical Technology

Pharmaceutical companies have also entered the social media marketing domain in compliance with governmental regulations to communicate directly with patients using covert persuasion methods such as collaboration with social media influencers. Discover the leading direct-to-consumer pharmaceutical marketing companies.

article thumbnail

Resolving challenges with product recovery in biopharma manufacturing

Pharmaceutical Technology

To learn more about how the 3M Harvest RC Chromatographic Clarifier is revolutionising biopharma production, download this specially commissioned white paper. Download to learn more. This can result in reductions in costs for our customers.” Please use the Intake form to object.

article thumbnail

EnACT patient-centric design in digital health development

pharmaphorum

The importance of patient and public involvement and engagement (PPIE) has been well documented, but there has, to date, been a lack of practical advice on how to implement and manage meaningful processes. . The result was the EnACT (engage, acknowledge, communicate, and trust and transparency) principles, as set out in the guide: .

article thumbnail

The Good, Bad, and Ugly side of 510(k)s—HP&M’s Early Experience with the eSTAR Template for 510(k)s: Part 2

The FDA Law Blog

If multiple people are reviewing and need to communicate changes it may be challenging to ensure all updates are incorporated. Lack of compatibility with cloud-based document sharing. It must first be downloaded, revised, and uploaded back to the system. Creation of unnecessary documents.